AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15603005 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational Problem Solving
Number of subjects: 0
Study 15603005 — intervention group
Group type: EXPERIMENTAL
Intervention: Job Seekers Workshop
Number of subjects: 0
Study 15603005 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined trainings
Number of subjects: 0
Study 11403336 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine 200 mg twice daily for 11 weeks
Number of subjects: 20
Study 11403336 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine 200 mg twice daily plus colchicine 0.6 mg twice daily for 12 weeks
Number of subjects: 20
Study 9230829 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized prospective follow-up study
Number of subjects: 204
Study 8434515 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous irrigation-drainage system
Number of subjects: 37
Study 8434515 — intervention group
Group type: COMPARATOR
Intervention: Evacuation via burr holes and gravity dependent closed-system drainage
Number of subjects: 37
Study 3312552 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg intravenously, 24 hours after birth)
Number of subjects: 32
Study 3312552 — intervention group
Group type: COMPARATOR
Intervention: Control group (no indomethacin given until symptomatic PDA developed)
Number of subjects: 32
Study 3312552 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin and Control
Number of subjects: 32
Study 29405106 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-led total sanitation (CLTS) intervention with training facilitators
Number of subjects: 171
Study 27015752 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fixation (open, direct reduction)
Number of subjects: 46
Study 27015752 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological fixation (indirect reduction)
Number of subjects: 46
Study 24727254 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 3627
Study 24727254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3627
Study 23579888 — intervention group
Group type: EXPERIMENTAL
Intervention: hemostatic agent‐contaminated and rinsing with water
Number of subjects: 100
Study 23579888 — intervention group
Group type: EXPERIMENTAL
Intervention: hemostatic agent‐contaminated and ethylene diamine tetraacetic acid (EDTA) application
Number of subjects: 100
Study 23579888 — intervention group
Group type: EXPERIMENTAL
Intervention: hemostatic agent‐contaminated and phosphoric acid application
Number of subjects: 100
Study 23579888 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 100
Study 20826420 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping combined with botulinum toxin A (BTX‐A) injection
Number of subjects: 20
Study 20826420 — intervention group
Group type: COMPARATOR
Intervention: Sham-taping combined with botulinum toxin A (BTX‐A) injection
Number of subjects: 20
Study 18565801 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 153
Study 18565801 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored counseling
Number of subjects: 153
Study 18565801 — intervention group
Group type: COMPARATOR
Intervention: Tailored counseling
Number of subjects: 153
Study 18565801 — intervention group
Group type: EXPERIMENTAL
Intervention: Run-in period
Number of subjects: 153
Study 16267427 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper tape applied to scars for 12 weeks
Number of subjects: 70
Study 16267427 — intervention group
Group type: COMPARATOR
Intervention: No postoperative intervention (Control)
Number of subjects: 70
Study 11919122 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day
Number of subjects: 20
Study 11919122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 10080458 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 220
Study 10080458 — intervention group
Group type: COMPARATOR
Intervention: Systemic thrombolysis with t-PA
Number of subjects: 220
Study 7723357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomazole 5 mg
Number of subjects: 12
Study 7723357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomazole 10 mg
Number of subjects: 12
Study 7723357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomazole 20 mg
Number of subjects: 12
Study 7723357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomazole 30 mg
Number of subjects: 12
Study 7723357 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomazole (all doses)
Number of subjects: 12
Study 2035280 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine brine drinking cure
Number of subjects: 0
Study 2035280 — intervention group
Group type: COMPARATOR
Intervention: Iodine-balneotherapeutic programme
Number of subjects: 0
Study 7038858 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfinpyrazone (S)
Number of subjects: 186
Study 7038858 — intervention group
Group type: COMPARATOR
Intervention: placebo (P)
Number of subjects: 186
Study 31276165 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (MET)
Number of subjects: 67
Study 31276165 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole plus azithromycin (MET+AZ)
Number of subjects: 67
Study 31276165 — intervention group
Group type: COMPARATOR
Intervention: Pre-antibiotic microbiota profiles
Number of subjects: 67
Study 28292299 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional training (classroom); n=16 CHAs in 8 churches
Number of subjects: 375
Study 28292299 — intervention group
Group type: COMPARATOR
Intervention: Technology training (web-based); n=14 CHAs in 7 churches
Number of subjects: 375
Study 28292299 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional and Technology groups
Number of subjects: 375
Study 27559855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger group (GG) - 500 mg ginger powder daily for 3 months
Number of subjects: 120
Study 27559855 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG) - 500 mg starch daily for 3 months
Number of subjects: 120
Study 24709512 — intervention group
Group type: EXPERIMENTAL
Intervention: DBM with rhBMP-2 (0.05 mg/mL)
Number of subjects: 69
Study 24709512 — intervention group
Group type: COMPARATOR
Intervention: DBM alone
Number of subjects: 69
Study 22983931 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation training
Number of subjects: 40
Study 22983931 — intervention group
Group type: COMPARATOR
Intervention: Strength training only
Number of subjects: 40
Study 22029664 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires answered in English
Number of subjects: 145
Study 22029664 — intervention group
Group type: COMPARATOR
Intervention: Questionnaires answered in Spanish
Number of subjects: 145
Study 16338740 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer risk counseling intervention
Number of subjects: 150
Study 16338740 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 150
Study 12841551 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration with 80 ml of 0.125 % Bupivacaine containing 5 mg of Phenylephrine (G2)
Number of subjects: 80
Study 12841551 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration with 80 ml of 0.9 % NaCl (G3)
Number of subjects: 80
Study 12841551 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration with Bupivacaine/Phenylephrine and 200 ml of normal saline containing 0.15 % of Lidocaine (G4)
Number of subjects: 80
Study 12841551 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1) with no local anaesthetics
Number of subjects: 80
Study 10825764 — intervention group
Group type: EXPERIMENTAL
Intervention: FFRmyo measurement before PTCA in Group 1 (AMI patients)
Number of subjects: 28
Study 10825764 — intervention group
Group type: COMPARATOR
Intervention: FFRmyo measurement before PTCA in Group 2 (non-AMI patients)
Number of subjects: 28
Study 10825764 — intervention group
Group type: EXPERIMENTAL
Intervention: QCA-determined percent diameter stenosis in Group 1 (AMI patients)
Number of subjects: 28
Study 8877075 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril, 20 mg/day by mouth
Number of subjects: 10
Study 8877075 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline conditions)
Number of subjects: 10
Study 1498583 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 1.0 mg
Number of subjects: 125
Study 1498583 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam 0.5 mg
Number of subjects: 125
Study 1498583 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 5 mg
Number of subjects: 125
Study 1498583 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 10 mg
Number of subjects: 125
Study 1498583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 6337171 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram with riboflavin marker
Number of subjects: 124
Study 6337171 — intervention group
Group type: COMPARATOR
Intervention: Riboflavin alone
Number of subjects: 124
Study 31146701 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction score for acute kidney injury (AKI) based on risk factors including hypertension history, heart rate > 100 bpm on admission, peak serum troponin I ≥ 100 μg/L, time from admission to coronary reperfusion > 120 min, Killip classification ≥ class 3 on admission, maximum dosage of intravenous furosemide ≥ 60 mg/d, shock during hospitalization, and baseline estimated glomerular filtration rate (eGFR) < 90 ml/min·1.73 m2.
Number of subjects: 6014
Study 29649669 — intervention group
Group type: EXPERIMENTAL
Intervention: 360-degree VR video
Number of subjects: 40
Study 29649669 — intervention group
Group type: EXPERIMENTAL
Intervention: 360-degree VR video + face to face teaching
Number of subjects: 40
Study 29649669 — intervention group
Group type: COMPARATOR
Intervention: 2D video teaching
Number of subjects: 40
Study 29649669 — intervention group
Group type: COMPARATOR
Intervention: 2D video teaching + face to face teaching
Number of subjects: 40
Study 26251312 — intervention group
Group type: EXPERIMENTAL
Intervention: OTC medication (containing cetylpyridinium chloride, dipotassium glycyrrhizate, and allantoin) applied twice a day for 12 weeks
Number of subjects: 61
Study 26251312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 26251312 — intervention group
Group type: EXPERIMENTAL
Intervention: OTC medication
Number of subjects: 61
Study 26251312 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 24521036 — intervention group
Group type: EXPERIMENTAL
Intervention: Penn Alcohol-Craving Scale (PCS)
Number of subjects: 147
Study 24521036 — intervention group
Group type: EXPERIMENTAL
Intervention: Desires for Drug Questionnaire (DDQ) desire and intention scores
Number of subjects: 147
Study 24521036 — intervention group
Group type: EXPERIMENTAL
Intervention: Desires for Drug Questionnaire (DDQ) negative reinforcement scores
Number of subjects: 147
Study 24521036 — intervention group
Group type: EXPERIMENTAL
Intervention: Desires for Drug Questionnaire (DDQ) control scores
Number of subjects: 147
Study 22100213 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural bupivacaine with hydromorphone
Number of subjects: 75
Study 22100213 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous thoracic epidural bupivacaine without hydromorphone
Number of subjects: 75
Study 22100213 — intervention group
Group type: COMPARATOR
Intervention: Continuous paravertebral infusion of bupivacaine
Number of subjects: 75
Study 22100213 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry in epidural bupivacaine with hydromorphone group
Number of subjects: 75
Study 22100213 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometry in epidural bupivacaine alone and continuous paravertebral infusion of bupivacaine
Number of subjects: 75
Study 20206845 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation (Group 1, n = 50)
Number of subjects: 100
Study 20206845 — intervention group
Group type: COMPARATOR
Intervention: Fascial pop technique (Group 2, n = 50)
Number of subjects: 100
Study 17493194 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher bone mineral density (BMD)
Number of subjects: 1042
Study 17493194 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of BMD
Number of subjects: 1042
Study 17493194 — intervention group
Group type: COMPARATOR
Intervention: Lowest three quartiles of BMD combined
Number of subjects: 1042
Study 15579581 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged vibration applied to the Achilles tendon at 100 Hz for 30 min
Number of subjects: 13
Study 12099976 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 4 mg/day
Number of subjects: 21
Study 12099976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 10442726 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented surgery (group A)
Number of subjects: 43
Study 10442726 — intervention group
Group type: COMPARATOR
Intervention: Prism adaptation (group P)
Number of subjects: 43
Study 7793717 — intervention group
Group type: EXPERIMENTAL
Intervention: Spine board with air mattress
Number of subjects: 20
Study 7793717 — intervention group
Group type: COMPARATOR
Intervention: Spine board without air mattress
Number of subjects: 20
Study 2254510 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 62
Study 2254510 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative response
Number of subjects: 62
Study 2254510 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonresponse
Number of subjects: 62
Study 2254510 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive response
Number of subjects: 62
Study 382150 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg t.d.s.)
Number of subjects: 48
Study 382150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31596719 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical sealant
Number of subjects: 100
Study 28668243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (200 μg) administered at 30 minutes, 90 minutes, and 4 hours after the first dose of nasal ketorolac
Number of subjects: 45
Study 28668243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 28668243 — intervention group
Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 45
Study 28668243 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 45
Study 26147654 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialty high amylose white rice 2 (Rondo)
Number of subjects: 18
Study 26147654 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialty high amylose white rice 1 (Dixiebelle)
Number of subjects: 18
Study 26147654 — intervention group
Group type: COMPARATOR
Intervention: Short grain rice
Number of subjects: 18
Study 23480968 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based follow-up counseling (FC) with 5 telephone contacts over a 2-month period.
Number of subjects: 928
Study 23480968 — intervention group
Group type: COMPARATOR
Intervention: Multi-component intervention program (MC) without telephone follow-up counseling.
Number of subjects: 928
Study 21813850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass azithromycin treatment
Number of subjects: 0
Study 19661847 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriophage treatment
Number of subjects: 42
Study 19661847 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 42
Study 16310932 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator route (TOR)
Number of subjects: 88
Study 16310932 — intervention group
Group type: COMPARATOR
Intervention: Retropubic route (RPR)
Number of subjects: 88
Study 16310932 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 14602361 — intervention group
Group type: COMPARATOR
Intervention: Placebo level of alcohol (0.04 g/kg)
Number of subjects: 45
Study 14602361 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.40 g/kg)
Number of subjects: 45
Study 14602361 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of alcohol (0.80 g/kg)
Number of subjects: 45
Study 10717252 — intervention group
Group type: EXPERIMENTAL
Intervention: Certoparin (low molecular weight heparin)
Number of subjects: 324
Study 10717252 — intervention group
Group type: COMPARATOR
Intervention: UF heparin (unfractionated heparin)
Number of subjects: 324
Study 8827423 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine infusion
Number of subjects: 24
Study 8827423 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 24
Study 1400008 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation (PROIN) at 2.62 g.kg‐1.day‐1
Number of subjects: 12
Study 1400008 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate supplementation (CHO) at 1.35 g.kg‐1.day‐1
Number of subjects: 12
Study 1400008 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended protein intake
Number of subjects: 12
Study 3155548 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial floxuridine
Number of subjects: 35
Study 31642725 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binding alone
Number of subjects: 32
Study 31642725 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (exercise therapy + abdominal binding)
Number of subjects: 32
Study 31642725 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 32
Study 31100345 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal stimulation
Number of subjects: 73
Study 31100345 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 73
Study 29410375 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter Group (N = 43)
Number of subjects: 85
Study 29410375 — intervention group
Group type: COMPARATOR
Intervention: No-Catheter Group (N = 42)
Number of subjects: 85
Study 26460695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinovac Enterovirus 71 vaccine
Number of subjects: 10077
Study 26460695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10077
Study 24879494 — intervention group
Group type: EXPERIMENTAL
Intervention: 100,000 units oral vitamin D3 every 3 months for 1 year
Number of subjects: 75
Study 24879494 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 75
Study 20974667 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-adjusted response-adaptive randomisation procedure using log-odds ratio within the Bayesian framework for longitudinal binary responses
Number of subjects: 0
Study 20974667 — intervention group
Group type: COMPARATOR
Intervention: Urn design by Biswas and Dewanji
Number of subjects: 0
Study 20129178 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic simillimum
Number of subjects: 30
Study 20129178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17568152 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 0.5 mg/kg/12 h for 9 days, then HC 0.5 mg/kg/24 h for 3 days
Number of subjects: 50
Study 17568152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17568152 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC)
Number of subjects: 50
Study 16280447 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg) + Vitamin D3 (200 IU)
Number of subjects: 195
Study 16280447 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1000 mg)
Number of subjects: 195
Study 16280447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheese (1000 mg calcium)
Number of subjects: 195
Study 16280447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 12123334 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated infusional ECF with G-CSF support
Number of subjects: 27
Study 12123334 — intervention group
Group type: COMPARATOR
Intervention: Conventional infusional ECF
Number of subjects: 27
Study 12123334 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 27
Study 11498911 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenshuailing Kou Fu Ye (SKFY)
Number of subjects: 0
Study 11498911 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenshuailing Guan Chang Ye (SGCY)
Number of subjects: 0
Study 11498911 — intervention group
Group type: COMPARATOR
Intervention: Coateg aldehyde oxystarch
Number of subjects: 0
Study 9691864 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline 1000 ml i.v. over a 30‐min period
Number of subjects: 0
Study 9691864 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch (200/0.5) 1000 ml i.v. over a 30‐min period
Number of subjects: 0
Study 7875275 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuttle walking test
Number of subjects: 29
Study 3278726 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h bed rest
Number of subjects: 80
Study 3278726 — intervention group
Group type: COMPARATOR
Intervention: Early (6 h post spinal) mobilization
Number of subjects: 80
Study 28971287 — intervention group
Group type: EXPERIMENTAL
Intervention: RCS diet (raw cornstarch)
Number of subjects: 0
Study 28971287 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (without starch)
Number of subjects: 0
Study 28971287 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence or absence of dietary carbohydrates (CBH)
Number of subjects: 0
Study 29231344 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug oil moxibustion
Number of subjects: 120
Study 29231344 — intervention group
Group type: COMPARATOR
Intervention: Simple moxibustion
Number of subjects: 120
Study 29231344 — intervention group
Group type: COMPARATOR
Intervention: Western medication (tamsulosin hydrochloride)
Number of subjects: 120
Study 26231378 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral impact exercise targeting the total hip and lumbar spine (n = 42 pairs)
Number of subjects: 107
Study 26231378 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral impact exercise targeting the distal radius (n = 24 pairs)
Number of subjects: 107
Study 26231378 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 107
Study 24001253 — intervention group
Group type: EXPERIMENTAL
Intervention: Walkstations (treadmills attached to desks) with feedback on usage
Number of subjects: 0